2022년 July 13일
Publication only available in Korean. Original Article
2021년 July 30일
RIGHT Fund (CEO Younbeen Kim / Research Investment for Global Health Technology Fund) has announced its selection of 2021 research grant award recipients for an […]
2021년 February 26일
Publication only available in Korean. Original Article
2021년 January 7일
This article is only available in Korean. Original Article
2020년 December 9일
This article is only available in Korean. Original Article
2020년 November 12일
Support R&D Projects for Vaccines, Therapeutics, Diagnostics and Digital Health Tackling Endemic and Emerging Infectious Diseases in Developing Countries Briefing Session to be Held at the […]
2020년 November 5일
This article is only available in Korean. Original Article
2020년 September 28일
Seoul, Republic of Korea, September 28th, 2020 – The RIGHT Fund (Younbeen Kim, CEO) was introduced as a new R&D funding agency in South Korea to […]
2020년 July 20일
This article is only available in Korean. Original Article
2020년 July 9일
This article is only available in Korean. Original Article
2020년 July 2일
This article is only available in Korean. Original Article
2020년 June 22일
Established the portfolio of 22 technologies tackling infectious diseases worth KRW 28.5 billion by selecting additional projects for this year R&D on respiratory infectious diseases including […]
2020년 June 3일
2nd Request for Proposals for Mid-to-Large Projects of This Year is Ongoing to Fight Against Infectious Diseases in Developing Countries, Following the Small Project Award in […]
2020년 May 25일
This article is only available in Korean. Original Article
2020년 May 20일
This article is only available in Korean. Original Article
2020년 March 10일
Invest in R&D projects for vaccines, therapeutics and diagnostics tackling infectious diseases in developing countries including COVID-19 Total three calls for proposals this year, including newly […]
2019년 October 25일
Younbeen Kim, CEO of RIGHT Fund, Participated in DCVMN General Assembly on October 21~23th This article is only available in Korean. Original Article
2019년 September 25일
One more investment for Bioneer’s drug-resistant tuberculosis diagnostic kit project…Final selection of five projects in 2019 including Korean companies Bioneer, LG Chem, SK Biotek, SD Biosensor […]
2019년 July 17일
Selected were 4 projects by LG Chem, MMV, SD Biosensor, EuBiologics 2019 RIGHT Fund Investment Forum is held on 17th with 2nd RFP announced Seoul, Republic of […]
2018년 October 1일
Korean government- pharmaceutical companies-Foreign foundation invested in the fund…First Request For Proposal to be released on Oct. 1st The Fund seeks for innovation in vaccines, therapeutics […]